- Flow Cyt
Supplier Data
Flow Cytometry - Anti-TIGIT antibody [EPR28147-69] (AB324717)
Flow cytometric analysis of Mouse spleen cells were treated with 5ug/ml of immobilized anti-CD3 and anti-CD28 for 24 hours (Lower left and right) / Untreated control (Upper left and right) cells labelling TIGIT with ab324717 at 1/500 dilution (0.1ug) / Upper right and Lower right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
Cells were co-stained with CD3 conjugated to Alexa Fluor® 647.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-TIGIT antibody [EPR28147-69] (AB324717)
Flow cytometric analysis of Mouse spleen cells were treated with 5ug/ml of immobilized anti-CD3 and anti-CD28 for 24 hours (Lower left and right) / Untreated control (Upper left and right) cells labelling TIGIT with ab324717 at 1/500 dilution (0.1ug) / Upper right and Lower right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
Cells were co-stained with CD25 conjugated to Brilliant Violet 421.
- Flow Cyt
Supplier Data
Flow Cytometry - Anti-TIGIT antibody [EPR28147-69] (AB324717)
Flow cytometric analysis of Mouse spleen cells were treated with 5ug/ml of immobilized anti-CD3 and anti-CD28 for 24 hours (Lower left and right) / Untreated control (Upper left and right) cells labelling TIGIT with ab324717 at 1/500 dilution (0.1ug) / Upper right and Lower right compared with a Rabbit monoclonal IgG (ab172730) / Left isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody).
Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.
Gated on viable cells.
Cells were co-stained with CD19 conjugated to PE/Cy7.
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-TIGIT antibody [EPR28147-69] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com